This is a continuation of September's episode 9. Dr. Michael Mortiz and Dr. Carlos Ayus take us through the history of intravenous fluids in children with the discovery of SIADH and the life-threatening hyponatremic encephalopathy cases that lead to a change in practice with the use of normal saline.

Dr. Mortiz is the director pediatric nephrology, along with the dialysis and transplant programs at UPMC Children’s Hospital of Pittsburgh. He most notably published the 2018 AAP Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Dr. Ayus is an adult nephrologist and professor of medicine at UC Irvine with an interest in electrolyte disorders. He has trained, and worked with, founding fathers of both pediatric and adult nephrology, such as Drs. Floyd Rector and Malcolm Holliday.

We would love feedback! Take this quick survey please :) https://s.surveyplanet.com/dmmriui5

Dr. Michael Mortiz and Dr. Carlos Ayus take us through the history of intravenous fluids in children with the discovery of SIADH and the life-threatening hyponatremic encephalopathy cases that lead to a change in practice with the use of normal saline.

Dr. Mortiz is the director pediatric nephrology, along with the dialysis and transplant programs at UPMC Children’s Hospital of Pittsburgh. He most notably published the 2018 AAP Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Dr. Ayus is an adult nephrologist and professor of medicine at UC Irvine with an interest in electrolyte disorders. He has trained, and worked with, founding fathers of both pediatric and adult nephrology, such as Drs. Floyd Rector and Malcolm Holliday.

Don’t miss out on an inside glimpse into how these experts managed to overturn popular opinion and accepted concepts in the field of nephrology during the last 20 years in order to save lives! This podcast is relevant to ANY PROVIDER who is administering IV fluids to hospitalized patients.

Questions/comments/feedback?? Email [email protected].

Dr. Keia Sanderson from UNC and Dr. Tahagod Mohamed from Nationwide Children's are two spectacular pediatric nephrologists with a special expertise and interest in neonatal nephrology. They comment on evidenced-based medicine in the field, along with the diagnosis, evaluation, management, follow-up and importance of neonatal acute kidney injury. 

*News Alert*! The Women in Nephrology Leadership Conference will be in Birmingham, AL from September 23-24, and will not disappoint! Follow this link for agenda and registration https://www.eventbrite.com/e/wining-strategies-to-lead-successfully-in-nephrology-tickets-367202020127. Questions? Email [email protected]

'Tis the season! Dr. Sharon Andreoli and Dr. Myda Khalid from Indiana University School of Medicine & Riley Hospital for Children discuss their clinical expertise in STEC-HUS.

Dr. Andrew Schwaderer, a Professor of Pediatrics at Indiana University School of Medicine and Riley Children's Hospital, discusses the presentation, evaluation and management of kidney stones in children.

We would greatly appreciate feedback for this podcast using this quick survey. Thanks! https://s.surveyplanet.com/dmmriui5 

Dr. Agnes Swiatecka-Urban, Division Head of Pediatric Nephrology and Professor at the University of Virginia and Dr. Emily Joyce, a pediatric nephrologist at Rainbow Babies and Children’s Hospital, discuss tubulointerstitial nephritis.

They have published a thorough and very helpful review article on the subject, which can be accessed here https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099107/.

We would love your feedback if you can please fill out this quick survey! https://s.surveyplanet.com/dmmriui5 

Dr. Chavers and Dr. Kizilbash are the guest experts this month from the University of Minnesota, here to discuss pediatric kidney transplantation. This is a continuation of last month's episode.

I am proud to report that UMN has performed over 1000 transplants in children, and the first and the most infant kidney transplants in the world!

Dr. Chavers is a professor of pediatrics and has a strong clinical research background, formerly the clinical research chair at the University of Minnesota and serves on the board of the NIH CKiD study and as a PI on a CDC NHANES study. She has published countless research papers regarding transplants and cardiovascular health in pediatric CKD patients.

Dr. Kizilbash is an assistant professor of pediatrics, fellowship director and current medical director of the kidney transplant team at the University of Minnesota. She is a prolific clinical researcher in transplant outcomes and has won numerous awards for her research and teaching skills.

Dr. Chavers and Dr. Kizilbash are the guest experts this month from the University of Minnesota, here to discuss pediatric kidney transplantation.

I am proud to report that UMN has performed over 1000 transplants in children, and the first and the most infant kidney transplants in the world!

Dr. Chavers is a professor of pediatrics and has a strong clinical research background, formerly the clinical research chair at the University of Minnesota and serves on the board of the NIH CKiD study and as a PI on a CDC NHANES study. She has published countless research papers regarding transplants and cardiovascular health in pediatric CKD patients.

Dr. Kizilbash is an assistant professor of pediatrics, fellowship director and current medical director of the kidney transplant team at the University of Minnesota. She is a prolific clinical researcher in transplant outcomes and has won numerous awards for her research and teaching skills.

Clifford Kashtan, MD and Michelle Rheault, MD give us the inside scoop on Alport Syndrome- when to consider the diagnosis, the role of a biopsy and genetic testing, benefits of early treatment and surveillance and management strategies.

Dr. Kashtan is a tenured Professor of Pediatrics at the University of Minnesota and an international expert in Alport Syndrome. He founded, and is still the director, of the Alport Syndrome Treatments and Outcomes (ASTOR) registry and is on the board of the Alport Syndrome Foundation. He has authored countless textbook chapters, articles and clinical research on the topic.

Dr. Rheault is an Associate Professor of Pediatrics and division chief of pediatric nephrology at the University of Minnesota. She has a special interest in Alport Syndrome, nephrotic syndrome and genetic diseases. She serves the board of Women in Nephrology as well as the Pediatric Nephrology Research Consortium. She is an active clinical researcher and “Tweet-iatrician.”

Please reach out with comments/suggestions/feedback! [email protected]

Peter Harris, PhD and Christian Hanna, MD, MS from the Mayo Clinic discuss the genetic implications, screening and management of ADPKD (autosomal dominant polycystic kidney disease) in pediatric patients. 

Dr. Harris is a Professor of Biochemistry/Molecular Biology and Medicine and the Director of the Mayo Translational PKD Center. His lab discovered the PKD1, PKHD1, TSC2 and other PKD genes. His laboratory employs genetic, cell biological, and animal studies to better understand the pathogenesis of various cystic kidney diseases. His work is funded by the NIDDK.

Dr. Hanna is an assistant professor of pediatrics, on faculty at the Mayo Clinic as a pediatric nephrologist with a special interest in pediatric cystic kidney diseases including ADPKD and others. His research interests include looking at biomarkers that correlate with kidney cysts burden and ADPKD progression in children.